Dosing Strategy for Itacitinib, a Selective JAK1 Inhibitor, for the Treatment of Ulcerative Colitis: 230. (October 2019) - Barbour, April; Zhang, Yan; Punwani, Naresh; Diamond, Sharon; Chen, Xuejun; Yeleswaram, Swamy